Holdings (38)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.96% |
| Divi's Laboratories Ltd | Healthcare | Equity | 9.51% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.45% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 4.78% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.78% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.49% |
| Cipla Ltd | Healthcare | Equity | 4.19% |
| Laurus Labs Ltd | Healthcare | Equity | 4.02% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.01% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.78% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 16.63% | 20.62% | 15.52% | NA% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 17.00% | 10.00% | 7.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.86%
Inclusive of GST
Exit load
Exit load of 0.50%, if redeemed within 3 months.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification.
Experience
Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.
Managed Schemes
Education
Mr. Nilay holds a degree in B.E (Computer) from D.J Sanghvi College of Engg & master’s in management studies in KJ Somaiya Institute of Management Studies & Research.
Experience
Prior to joining ITI Mutual Fund, he has with Axis Asset Management Company, SBI Life Insurance Company Ltd & MAQ Software Pvt Ltd.